corporate affairs and communications, reporting directly to chairman and
chief executive officer Sidney Taurel. He will be a member of the company's
policy and strategy committee, the corporate operations committee, and the
senior management council.
Azar will lead the company's teams that are responsible for
international, federal, and state government affairs, public policy
planning and development, external and internal communications, corporate
branding, and community and public relations. Azar will also lead the
company's efforts in maximizing the value of health information technology
and in fighting against the spread of counterfeit medicines.
Azar brings to Lilly a distinguished record of achievement in both the
public and private sectors. Until February 3, 2007, he was the United
States Deputy Secretary of Health and Human Services (HHS), where he worked
closely with Secretary Mike Leavitt and served for almost two years as the
chief operating officer of the largest civilian department in the federal
government. Azar supervised all operations of the HHS, including the
regulation of food and drugs, Medicare, Medicaid, medical research, public
health, welfare, child and family services, disease prevention, Indian
health, mental health services, emergency preparedness and response, and
many other activities. Agencies under his direction included, among others,
the Food and Drug Administration, the Centers for Medicare and Medicaid
Services, the National Institutes of Health, and the Centers for Disease
Control and Prevention. He was a key member of President Bush's leadership
team, contributing extensive policy, legal, and management expertise.
Prior to his tenure as Deputy Secretary, Azar served for four years as
the General Counsel of the HHS. Before entering the government, he was a
partner at the Washington, D.C., law firm of Wiley, Rein & Fielding. Azar
also clerked at the Supreme Court of the United States for Associate
Justice Antonin Scalia. He is a graduate of Dartmouth College and Yale Law
School, and will be moving to Indianapolis with his wife Jennifer and their
two young children.
"We are very pleased to have someone of Alex's caliber join the
leadership team here at Lilly," said Taurel. "He brings a combination of
distinguished government service and private practice, and he has a track
record of strong leadership. Alex has been a leading advocate for the role
that pharmaceuticals play in preventing, treating and curing disease, and
he will be a great addition to the company."
Said Azar, "After leaving public service back in February, I began to
consider ways I could continue to play an active role in the healthcare
arena. Lilly is providing me an excellent opportunity to do just that. I am
excited about joining the company's leadership team, and I look forward to
contributing to the company's efforts to bring innovative medicines to
patients around the world. The pharmaceutical industry operates in a
challenging environment, and I am anxious to begin addressing many of those
challenges through this new role."
The company also announced that Anne Nobles will assume the role of
vice president for compliance and enterprise risk management, and she will
serve as Lilly's chief compliance officer. Nobles, a graduate of Harvard
University and Georgetown University Law School, has been with Lilly for
over 16 years and has held a variety of leadership roles in public affairs,
regulatory affairs, public policy, business customer strategies, product
team leadership, and corporate affairs. Nobles will report directly to
Taurel and will be a member of both the corporate operations committee and
the senior management council.
Said Taurel, "Anne's legal background and her broad experiences here at
Lilly make her the ideal person to assume the role of the company's chief
compliance officer. We are committed to conducting ourselves with integrity
and to being in compliance with all laws and regulations, and having
someone with Anne's qualifications in this important role is evidence of
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of first-in-class and best-in-class pharmaceutical products by
applying the latest research from its own worldwide laboratories and from
collaborations with eminent scientific organizations. Headquartered in
Indianapolis, Ind., Lilly provides answers -- through medicines and
information -- for some of the world's most urgent medical needs.
Additional information about Lilly is available at http://www.lilly.com.